| Name | Title | Contact Details |
|---|
We are a vertically integrated cannabis company led by an industry-leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem.
Ayr Strategies Inc.is a vertically integrated multi-state operator in the U.S. cannabis sector, with an initial anchor portfolio in Massachusetts and Nevada. Through its five operating companies, Ayr is a leading cultivator, manufacturer and retailer of cannabis products and branded cannabis packaged goods.
Luxury Brand Partners develops and nurtures prestige artist-driven beauty brands, with a focus on innovation and a passion for the creative mind. With offices in Miami and New York City, our portfolio of companies, including Oribe, R+Co, Smith & Cult, V76, and IGK, offer high-performance products and top-of-the-line education informed by both an artistic and a business perspective.
1906`s mission is to create a new category of premium edibles, marrying the benefits of cacao, cannabis, and ethnobotanical ingredients, designed to appeal to responsible, informed, health conscious adults.
ChroMedX Corp. is a medical technology company focused on the development of novel, handheld medical devices for diagnostic testing at the patient`s bedside. HemoPalm, the Company`s lead product is the only handheld blood analysis system which combines Blood Gases & Electrolytes with full CO-oximetry. It has a single-use cartridge/handheld reader format, providing the simplest, most rapid and accurate testing process for use in management of critical care patients. Current blood gas systems require purchase of a second device to carry out CO-oximetry measurements. In addition, HemoPalm has the ability to draw capillary blood directly from pin-prick sites into the cartridge, as an alternative to the commonly required, risk-associated arterial blood draws. ChroMedX Corp. technologies are protected by the Company`s issued and pending patents, covering blood/plasma/serum collection, and processing and analysis.